baber/WOPTO huggingface dataset:
Patent IL-75143-A0 (IL)
Title: Thermosetting,free radical curable unsaturated polymer resin composition and method of reducing gas generation in curing thermosetting,free radical curable unsaturated polymer resin compositions
IPC: C08F299/00
Filed: 1985-05-09
Abstract: A thermosetting, free radical curable unsaturated polymer resin composition and a method of curing thermosetting, free radical curable, unsaturated polymer resin compositions having a pH greater than 4.5 measured as a 10 weight percent methanol solution and containing a tertiary amine as an esterification catalyst and/or an accelerator, such resin being admixed with a copolymerizable monomer, wherein a curing system of a ketone peroxide and a redox active metal salt is employed. An effective amount of an organic sulfonic acid is added to the resin prior to curing, whereby by gas generation upon curing is reduced.
Patent IL-81056-A0 (IL)
Title: Thioethers,their preparation and pharmaceutical compositions containing them
IPC: A61K31/215
Filed: 1986-12-22
Abstract: Novel asymmetric thioethers of the formula    <IMAGE>  (I)  in which the general symbols have the following meanings: R0 represents hydrogen or C1-7-alkanoyl, R1 represents C1-3-alkyl which may be substituted by one or more halogen atoms having an atomic number of at most 17, R2 represents an aliphatic radical having from 5 to 15 carbon atoms, A represents ethylene, a single bond or vinylene, B1 represents C1-7-alkylene or phenylene, B2 represents a single bond, ethylene or phenylene, and M represents an aromatic radical of the partial formula    <IMAGE> (M)   in which the symbols have the following meanings: R3 represents hydrogen or C1-4-alkyl, X represents NH, O, S or if R4 represents hydrogen, a single bond, one of the symbols R4 and R5 represents hydrogen and the other represents the group -CO-R6, or R4 and R5 together represent the radical -CO-C(R6)=C(R7)-or-CO-C(R7)=C(R6)-or R4 R5, together with X, represent the radical -N=C(R8)-C(R6)=CH-, in which R6 represents -(CH2)b-COOR3 (in which b=0 to 2) R7 represents hydrogen or C1-4-alkyl and R8 represents hydrogen, methyl, mythoxy or halogen, and their salts are active as leucotriene antagonists since they eliminate the contractions of smooth muscles brought about by leucotrienes, and are therefore suitable for the treatment of allergic, especially asthmatic, conditions.
Patent IL-81543-A0 (IL)
Title: Unsaturated amino acids
IPC: C07F9/38
Filed: 1987-02-11
Abstract: Phosphorus-contg. unsaturated amino acids of formula (I) and their salts are new: R1 = hydroxy or etherified hydroxy; R2 = H, alkyl, hydroxy or etherified hydroxy; R3 = H, alkyl, haloalkyl, hydroxyalkyl, lower alkoxyalkyl, arylalkyl, lower alkenyl, halogen or aryl; R4 = H, alkyl or arl; R5 = H or alkyl; R6 = carboxy or esterified or amidated carboxy; R7 0 amino opt. substd. by alkyl or aryl; A = opt. alkyl-substd. 1-3C alpha, omega-alkylene or a direct bond; B = methyleue or direct bond; provided that A and B are both direct bonds. Specifically claimed are 9 cpds. including E-2-amino-5- phosphono-3-pentenoic acid, E-2-amino-4-methyl-5-phosphono -3-pentenoic acid, and E-2-amino-4-methyl -5-phosphono-3-pentenoic acid ethyl ester.
Patent IL-82541-A0 (IL)
Title: 4(5)-substituted imidazole derivatives,and intermediates and processes for their preparation
IPC: C07D233/56
Filed: 1987-05-15
Abstract: The invention provides 4(5)-substituted imidazole derivatives of formula <CHEM> and their acid addition salts, in which either X is -CH2- and R1 is -CN, -COOH, COO(lower alkyl), -CHO, -CO (lower alkyl), lower alkyl of 3 to 5 carbon atoms, lower alkenyl, or lower (hydroxy alkyl) or X is   -@@CH2R)-, -C(:CH-R)- or -CH(CH2R)-, where R is hydrogen or lower alkyl, and R1 is lower alkyl, and R3 and R4 are each hydrogen, methyl, ethyl, methoxy, or halogen, and novel intermediates and processes for their preparation. These compounds, in particular when R1 is lower alkyl, lower alkenyl, or lower (hydroxy alkyl), possess valuable pharmacological properties and are useful especially as selective  alpha 2-receptor antagonists.
Patent IL-86133-A0 (IL)
Title: Beta-d-phenylthioxylosides,their preparation and pharmaceutical compositions containing them
IPC: C07C323/09
Filed: 1988-04-20
Abstract: The present invention relates, by way of novel industrial products, to osides selected from the group consisting of: (i) the  beta -D-phenylthioxylosides of the formula:   <IMAGE>   in which: R represents a hydrogen atom, a halogen atom, a nitro group or a cyano group, A represents the sulfur atom or the oxygen atom, B represents a CH2, CHOH or CO group and Y represents the hydrogen atom or an acyl group; and (ii) epimers thereof when B is CHOH. These products are useful in therapy as antithrombotics.
Patent AU-PO710497-A0 (AU)
Title: Casting metal strip
IPC: B22D11/00
Filed: 1997-06-02
Abstract: Twin roll casting has been applied with some success to non-ferrous metals, which solidify rapidly on cooling. The same, however, is not true for ferrous metals, as it has not been possible to achieve sufficiently rapid and even cooling of metal over the casting surfaces of the rolls. This problem has been overcome by utilising a metallic surface for the rolls, which has a high affinity for the molten steel of the casting pool and a melting temperature greater than the temperature of the casting surface. The molten steel produces extremely good wetting of the casting surface of the roll, resulting in a wetting angle of the molten steel on the casting surface of less than 40 DEG . Preferably, this wetting angle is less than 20 DEG  and the casting surface has an Arithmetic Mean Roughness Value (Ra) of less than 10 microns. These desirable properties on the roll surface are achieved by selecting an at least partially amorphous alloy of two constituents. Preferably, the alloy is a fully amorphous alloy of the nickel-phosphorus systemcontaining about 10 % phosphorus and the balance nickel, which may be applied by eletroless coating. This roll surface prevents the build-up of iron oxide on the casting surfaces of the rolls, which build-up interferes with the uniform conduction of heat away from the molten steel, resulting in simultaneous solidification of the  delta  and  gamma  iron phases (0.01-0.18 %C), which causes a surface defect, known as "crocodile-skin". The net effect of utilising this amorphous alloy for the surface of the casting roll is a superior and uniform conduction of heat away from the molten steel, rapid transformation of the steel's microstructure into the wholly austenitic ( gamma ) region, exhibited by fine prior austenite grain boundaries conforming to dendritic grain boundaries and absence of "crocodile-skin" surface defects on the cast strip.
Patent FI-20002151-A0 (FI)
Inventor: PAATERO LAURI
IPC: H04L9/32
Filed: 2000-09-29
Abstract: The present invention relates to a device comprising an inlet (2) for receiving an input, calculating means (P) for calculating a response by means of the input, a secret key and a calculation algorithm, the calculation algorithm utilizing a sliding window method, and an outlet (3) for forwarding said response. In order to make the secret key even more difficult for an external attacker to find out, the device further comprises a random number generator (RND) to generate at least some of the multipliers utilized by the calculating means (P) in the sliding window method.
Patent FI-20106335-A0 (FI)
Inventor: REHTIJAERVI PEKKA AARNE
IPC: H04L51/00
Filed: 2010-12-17
Abstract: A user terminal with an application customized for terminal-specific properties. Terminal 1 has a version of the customized application. An application server stores ID of the user terminals and/or subscriptions, a template for the customized application and a feature set for several terminal types. Terminal 1 sends Terminal 2 a community message with a link directing Terminal 2 to the application server. Link activation in Terminal 2 initiates a request to the application server that determines an ID and type of Terminal 2 based on the request. Based on the type, the application server determines terminal-specific properties Terminal 2. Based on the template and the terminal-specific properties, the application server creates the customized application having a feature to send the community message to other terminals. The customized application is delivered to Terminal 2.
Patent IL-100015-A0 (IL)
Title: Mono-n-substituted 1,4,7,10-tetraazacyclododecane derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IPC: A61K49/00
Filed: 1991-11-08
Abstract: Tetraazacyclododecane compounds of general formula I    <IMAGE>  (I)  in which E and Q are defined herein and their salts with inorganic and/or organic bases, amino acids or amino acid amides are valuable pharmaceutical agents.
Patent IL-101105-A0 (IL)
Title: Fluoroalkenyl compounds and their use as pest repellants
IPC: C07C309/73
Filed: 1992-02-28
Abstract: Trifluorobutenoic acid, its methyl ester and a process of preparation thereof.
Patent IL-105810-A0 (IL)
Title: Erythromycin derivatives
IPC: C07D407/00
Filed: 1993-05-25
Abstract: A compound represented by general formula [I] or a salt thereof, being extremely reduced in the decomposability by gastric juice as compared with other known erythromycin derivatives and having an excellent activity of promoting the movement of digestive tracts, wherein R1 represents hydrogen or acyl; R2 and R3 may be the same or different from each other and each represents hydrogen, hydroxy, acyloxy or amino, or alternatively R2 and R3 are combined together to represent =O or =NOR10, wherein R10 represents hydrogen or lower alkyl; R4 represents hydrogen or lower alkyl; and Y represents -NR5R6 or -N<+>R7R8R9X<->, wherein R5, R6, R7, R8 and R9 may be the same or different from one another and each represents hydrogen, optionally substituted lower alkyl, lower alkenyl, lower alkynyl or cycloalkyl, or a 3- to 7-membered heterocyclic group containing oxygen, nitrogen or sulfur as the heteroatom, and X represents an anion, provided that a pair of R5 and R6 and a pair of R7 and R8 may be each combined with the adjacent nitrogen atom to represent azacycloalkyl. <CHEM>
Patent IL-107574-A0 (IL)
Title: Process and intermediates for producing finasteride and novel polymorphic forms thereof
IPC: C07J9/00
Filed: 1993-11-11
Abstract: Disclosed is a new process for producing finasteride which involves reacting the magnesium halide salt of 17β-carboalkoxy-4-aza-5α-androst-1-en-3-one with t-butylamino magnesium halide, present in at least a 2:1 molar ratio to the ester, formed from t-butyl amine and an aliphatic/aryl magnesium halide at ambient temperature in an inert organic solvent under an inert atmosphere followed by heating and recovering the product finasteride.Also disclosed are two polymorphic crystalline Forms I and II of finasteride, and methods of their production.
Patent IL-110891-A0 (IL)
Title: System and method for access control for portable data storage media
IPC: G09C1/00
Filed: 1994-09-08
Abstract: The system and method of the present invention provides the support of high density removable media, such as CD-ROM or MO, to be used as a distributed media for storing data where access thereto is securely restricted. Through this system and method, the secure periodic distribution of several different sets of data information to the end user is achieved with access control selectively performed by at the user's site through communication with the billing/access center. User billing is based on the purchase of the decryption access codes as indicated by the access code attributes encoded on the media. Access code availability is further controlled by selectively providing for updates of decryption access codes.
Patent IL-114513-A0 (IL)
Title: A method for rapid signal acquisition in a satellite communication system
IPC: H04B7/216
Filed: 1995-07-09
Abstract: The signal acquisition process of the present invention enables a radio to rapidly acquire a pilot signal from a satellite after the radio has been out of contact with the satellite for a length of time. The radio first acquires a satellite pilot signal and determines its position in relation to the earth. If the radio is now shut off or loses track of the pilot signal for some other reason, the radio keeps track of the length of time that it has been out of contact with the satellite. This length of time enables the radio to estimate the extent of possible position changes and, therefore, which satellites might be in view and their relative positions to the radio. This allows the radio to make assumptions about variables such as the Doppler shift of the signal that reduces the uncertainty inherent in the acquisition process and the size of the window that must be searched.
Patent IL-117214-A0 (IL)
Title: Dna molecules their preparation and uses in gene therapy
IPC: C12N5/10
Filed: 1996-02-21
Abstract: Double-stranded DNA molecules characterised in that they are circular and in that they essentially include one or more genes of interest.
Patent IL-131969-A0 (IL)
Title: Grille armor applique
IPC: F41H7/03
Filed: 1998-03-24
Abstract: The invention provides a grille armor system for use on a armored vehicle. The grille armor system adds an applique  grille to a grille to increase   the protection provided by the grille armor        system. The applique grille is designed          ed to add a minimal profile. The applique            grille also is designed to allow maximum air flow through the appliqu+E,acu e+EE  grille. In the preferred embodiment, the appliqu+E,acu e+EE  grille is made of 4 mm thick steal bars place 8 mm apart to provide added protection to aluminum S-shaped louvers against high velocity 20 mm fragment simulating projectiles.\!
Patent IL-135999-A0 (IL)
Title: Tamper-evident form for securely carrying information
IPC: B42D15/02
Filed: 1998-09-18
Abstract: Variable confidential information (12) is printed over scrambling pattern (14) which is formed of thermochromatic ink. Information (12) cannot be read due to the presence of the underlying scrambling pattern. The information becomes readable when heat is applied to the thermochromatic ink and the optical properties of the thermochromatic ink are altered. Preferably, the alteration of the optical properties of the thermochromatic ink is irreversible. <IMAGE>
Patent IL-139978-A0 (IL)
Title: Combined laser/flir optics system
IPC: G05B23/02
Filed: 2000-11-29
Abstract: In a FLIR/laser based targeting and imaging system, the ability to recognize, detect, locate, and/or track targets in an area of interest is significantly improved by reducing the fixed and dynamic alignment errors between the IR LOS and the laser LOS. Fixed alignment errors are reduced with an improved internal boresight module and corresponding boresight method. Dynamic alignment errors are reduced with an opto-electric subsystem that employs a single pitch bearing and a common pitch/yaw afocal for both the laser energy and the IR energy. A segmented window in the system housing includes a circular EMI grid pattern which significantly reduces the amount of off-axis EMI entering the optical pathways, and improved signal processing techniques are employed to enhance the quality of the IR image after the image has been digitized.
Patent IL-143187-A0 (IL)
Title: Flow limiter
IPC: E03C1/084
Filed: 1999-11-12
Abstract: A device for controlling liquid flow in a conduit which is of a hat-like configuration defined by a cylindrical base part having a flange part at one end and a closure part at another end joined thereto by an integral spring which bends to permit through-flow of liquid through a peripheral gap between the body part and the closure part. The gap is of a stepwise progression including either an abrupt or curved step. The gap has a medial gap portion and opposite gap portion ends which are relatively sized to effect the stepwise progression.</PTEXT>
Patent IL-143654-A0 (IL)
Title: Improved methods for wire-scribing filament circuit patterns with planar and non-planar portions; improved wire-scribed boards, interconnection cards, and smart cards made by these methods
IPC: H05K7/06
Filed: 1999-12-07
Abstract: An apparatus and method of forming filament circuit patterns with planar and non-planar portions and interconnection cards, smart cards or optical fiber circuit cards formed therefrom are provided. A filament circuit path is scribed by moving a filament guide and a substrate relative to one another, and dispensing a filament on, or in the vicinity of, a surface of the substrate. The filament or the substrate or both have adhesive surface(s). The adhesive surface is capable of being adhesively actuated by application of energy. Energy is applied simultaneous with, or subsequent to, scribing. A portion of the filament circuit pattern is planar and another portion is non-planar. The non-planar portion traverses but does not contact or adhere to a pre-selected area of the substrate. The pre-selected area corresponds with a pad, a contact pattern, a hole, a slot, a raised feature, a part of the previously scribed planar portion of the pattern, and a filament termination point. Alternately, the non-planar portion may be embedded below the surface of the substrate. Another planar portion of the filament circuit traverses the non-planar portion but does not contact or adhere to a pre-selected part of the previously scribed non-planar portion. According to the above method wire-scribed circuit boards are formed including interconnection cards, smart cards or optical fiber circuit cards.
Patent IL-146793-A0 (IL)
Title: Reinforced flexible hose and method for the production thereof
IPC: F16L11/08
Filed: 2000-06-10
Abstract: A reinforced flexible hose comprising as least a first inner extruded tubular layer and at least a second extruded tubular layer with a tubular reinforcement fabric provided between said first and second hoses. The two tubes are joined so as to form a homogeneous unit by their mutual contact surfaces, by gluing or molecular adhesion, for example. The end portion of the hose increases in width so much as to make it possible to achieve a better mechanical hold with the standard junctions to which it is bound to be fixed. The thickness increases at the end portions may either be constant along its whole length, or start gradually toward the end.
Patent IL-151449-A0 (IL)
Title: Method for production of spirocyclic tetronic acid derivatives
IPC: C07D307/94
Filed: 2001-03-05
Abstract: The present invention relates to a novel process for preparing compounds of the formula (I)by reacting compounds of the formula (II)with a base and compounds of the formula (III)in which X, Y, Z, n, G, A, B, R1, R8 and Hal are each as defined above.
Patent IL-155996-A0 (IL)
Title: Microbiological method for producing amides
IPC: C12N9/78
Filed: 2002-01-08
Abstract: The present invention provides for microorganisms capable of tolerating acetonitrile concentrations of at least 3 M, enzyme extracts obtainable from these microorganisms, a nitrile hydratase obtainable from these microorganisms, a method for preparing amides using these microorganisms, the enzyme extracts or the nitrile hydratase obtainable therefrom, and a method for removing acetonitrile from solutions using these microorganisms, the enzyme extracts or the nitrile hydratase obtainable therefrom.
Patent IL-156981-A0 (IL)
Title: Nickel-base alloy
IPC: F02C7/00
Filed: 2003-07-17
Abstract: A castable and weldable nickel-base alloy that exhibits a desirable balance of strength and resistance to corrosion and oxidation suitable for gas turbine engine applications. A suitable composition for the alloy consists essentially of, by weight, 10% to 25% cobalt, 20% to 28% chromium, 1% to 3% tungsten, 0.5% to 1.5% aluminum, 1.5% to 2.8% titanium, 0.8% to 1.45% columbium, tantalum in an amount less than columbium and Cb + 0.508Ta is 1.15% to 1.45%, 0.001% to 0.025% boron, up to 0.4% zirconium, 0.02% to 0.15% carbon, with the balance essentially nickel and incidental impurities.
Patent IL-164250-A0 (IL)
Title: Chimeric pancreas
IPC: A61K35/12
Filed: 2003-03-24
Abstract: Novel methods, tissues and compositions for increasing the pancreatic mass of a mammalian recipient including harvesting immature pancreatic tissue from a mammalian donor and transplanting said tissue into the peritoneal cavity of a mammalian recipient under conditions that allow the pancreatic tissue to become vascularized and mature, thereby developing a functioning chimeric, endocrine pancreas that produces at least insulin in the recipient. The invention also includes mammalian immature pancreatic tissue adapted for transplantation into the peritoneal cavity of a mammalian recipient for increasing the pancreatic mass of the mammalian recipient as well as methods and compositions for treatment of the pancreatic tissue, recipient immunosuppression and recipient co-stimulatory blockade.
Patent IL-185342-A0 (IL)
Title: Fluid consuming battery with fluid regulating system
Filed: 2007-08-16
Abstract: The invention is an electrochemical battery cell with a fluid consuming electrode, such as an oxygen reduction electrode, and a fluid regulating system. The fluid regulating system includes a valve for adjusting the rate of passage of the fluid to the fluid consuming electrode. It is operated by an actuator that responds (e.g., by deforming) to changes in a potential applied across the actuator to open or close the valve. The applied potential can be the cell potential or an adjusted potential. The potential applied across the actuator can vary according to the need for more or less fluid in the fluid consuming electrode. The valve can be contained within the cell housing, for example between the fluid consuming electrode and one or more fluid entry ports in the cell housing, or it can be located outside the cell housing.
Patent IL-193777-A0 (IL)
Title: Modified botulinum toxins and pharmaceutical compositions containing the same
Filed: 2008-08-31
Abstract: Modified botulinum toxin (BoNT) which exhibits a natural heavy chain and a modified light chain, where the light chain is modified at its N terminal end that exhibits a chain extension in the direction from the N- to the C-terminal end. Modified botulinum toxin (BoNT), which exhibits a natural heavy chain and a modified light chain, where the light chain is modified at its N terminal end that exhibits a chain extension in the direction from the N- to the C-terminal end, with a structure of (-(Cy) n-(tag) m-(X) l). Cy : cysteine residue, where at least one of the cysteine residues in the chain extension is coupled to at least a chain polyethylene glycol; tag : any tag, preferably histidine tag or streptavidin tag; X : any naturally occurring amino acid; n : 1-50; m : 0 or 1; and l : 0-50. Independent claims are included for: (1) a composition for human and/or veterinary medicine comprising the modified botulinum toxin; (2) a nucleic acid which codes for the modified botulinum toxin; (3) a vector comprising the nucleic acid; and (4) a host cell comprising the vector. ACTIVITY : Muscular-Gen; Neuroprotective; Muscle-Relaxant; Antiinflammatory; Gastrointestinal-Gen; Inotropic; Dermatological. MECHANISM OF ACTION : None given.
Patent IL-206396-A0 (IL)
Title: Antitumoral compounds
Filed: 2010-06-15
Abstract: A compound of general formula (I)   
wherein A, Y, W, R 1 , R 2 , R 3 , R 4 , R 5 , and R 6  take various meanings for use in the treatment of cancer.